ProfileGDS5678 / 1436649_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 13% 13% 13% 82% 13% 13% 12% 13% 22% 13% 13% 13% 13% 13% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.3445313
GSM967853U87-EV human glioblastoma xenograft - Control 22.3160413
GSM967854U87-EV human glioblastoma xenograft - Control 32.3197613
GSM967855U87-EV human glioblastoma xenograft - Control 46.0654982
GSM967856U87-EV human glioblastoma xenograft - Control 52.2674813
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.3745213
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.334812
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.3008113
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.4827422
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.306413
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.3126513
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.2911213
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.3137513
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.3185613